Cyclin E overexpression in human gallbladder carcinomas.

  • Authors:
    • N Eguchi
    • K Fujii
    • A Tsuchida
    • S Yamamoto
    • T Sasaki
    • G Kajiyama
  • View Affiliations

  • Published online on: January 1, 1999     https://doi.org/10.3892/or.6.1.93
  • Pages: 93-99
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The expression of cyclin E, one of the important positive cell cycle regulators, was examined immunohistochemically in gallbladder carcinomas. Cyclin E gene product was detected in 58 (49%) out of 118 cases. The degree of cyclin E expression was not associated with any clinicopathological factor including histology, the depth of tumor invasion, tumor stage and patient prognosis. Cyclin E expression was not correlated with that of p53 protein statistically, whereas it was correlated with the proliferative activity of the tumor cells by PCNA (p<0.05). These results suggested that cyclin E expression may confer progression of gallbladder carcinomas.

Related Articles

Journal Cover

Jan-Feb 1999
Volume 6 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Eguchi N, Fujii K, Tsuchida A, Yamamoto S, Sasaki T and Kajiyama G: Cyclin E overexpression in human gallbladder carcinomas.. Oncol Rep 6: 93-99, 1999
APA
Eguchi, N., Fujii, K., Tsuchida, A., Yamamoto, S., Sasaki, T., & Kajiyama, G. (1999). Cyclin E overexpression in human gallbladder carcinomas.. Oncology Reports, 6, 93-99. https://doi.org/10.3892/or.6.1.93
MLA
Eguchi, N., Fujii, K., Tsuchida, A., Yamamoto, S., Sasaki, T., Kajiyama, G."Cyclin E overexpression in human gallbladder carcinomas.". Oncology Reports 6.1 (1999): 93-99.
Chicago
Eguchi, N., Fujii, K., Tsuchida, A., Yamamoto, S., Sasaki, T., Kajiyama, G."Cyclin E overexpression in human gallbladder carcinomas.". Oncology Reports 6, no. 1 (1999): 93-99. https://doi.org/10.3892/or.6.1.93